Skye Bioscience, Inc.SKYENASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average.
Left:
||||
Free cash flow yield
Latest
-25.99%
↑ 53% above average
Average (9y)
-54.79%
Historical baseline
Range
High:-7.51%
Low:-143.76%
CAGR
-2.1%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | -25.99% | +64.5% |
| 2023 | -73.28% | +49.0% |
| 2022 | -143.76% | -362.9% |
| 2021 | -31.05% | +52.7% |
| 2020 | -65.67% | -89.8% |
| 2019 | -34.60% | -360.8% |
| 2018 | -7.51% | +89.6% |
| 2017 | -72.30% | -16.1% |
| 2016 | -62.29% | -98.0% |
| 2015 | -31.46% | - |